Indivior PharmaceuticalsINDV +1.31%69 Days Inventory is 350.17 as of Mar. 2026, which is 42% above its 10-year median of 247.16. GuruFocus rates INDV with a GF Score™ of 69/100 and a GF Value™ of $22.98 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 916 Drug Manufacturers companies, Indivior Pharmaceuticals ranks worse than 72.27% on this metric.
The historical rank and industry rank for Indivior Pharmaceuticals's Days Inventory or its related term are showing as below:
INDV'
s Days Inventory Range Over the Past 10 Years
Min: 151.8 Med: 247.16 Max: 312.32
Current: 234.08
During the past 13 years, Indivior Pharmaceuticals's highest Days Inventory was 312.32. The lowest was 151.80. And the median was 247.16.
INDV's Days Inventory is ranked worse than 72.27% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs INDV: 234.08
Indivior Pharmaceuticals's Days Inventory
declined
from Mar. 2025 (353.59) to Mar. 2026 (350.17).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Indivior Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.26.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Indivior Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.48.
Indivior Pharmaceuticals (NAS:INDV) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Indivior Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Indivior Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Indivior Pharmaceuticals Days Inventory Related Terms
Indivior Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INDV vs AMRX, KNSA, LQDA: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Indivior Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indivior Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Indivior Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Indivior Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indivior Pharmaceuticals (INDV) has a Days Inventory of 350.17 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Indivior Pharmaceuticals and its competitors. This is 42% above median its historical median of 247.16. Over the past decade, Indivior Pharmaceuticals' Days Inventory has ranged from 151.80 to 312.32. According to the industry distribution chart, Indivior Pharmaceuticals ranks #662 out of 916 companies in the Drug Manufacturers industry, placing it in the top 72.3%.
Is Indivior Pharmaceuticals' Days Inventory too high?
Indivior Pharmaceuticals' current Days Inventory of 350.17 is 42% above median its 10-year median of 247.16. Over the past 10 years, this metric has ranged from a low of 151.80 to a high of 312.32. The Drug Manufacturers industry median Days Inventory is 164.43. Indivior Pharmaceuticals' value of 350.17 is 113% above this industry median. Based on the distribution chart, Indivior Pharmaceuticals ranks #662 out of 916 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Indivior Pharmaceuticals has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Indivior Pharmaceuticals' Days Inventory compare to AMRX and KNSA?
According to the Drug Manufacturers industry distribution chart, Indivior Pharmaceuticals ranks #662 out of 916 companies for Days Inventory. This places Indivior Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 164.43. Indivior Pharmaceuticals' value of 350.17 is 113% above this benchmark. Historically, Indivior Pharmaceuticals' own Days Inventory has ranged from 151.80 to 312.32 over the past decade. While the company's 10-year median is 247.16 vs. the industry median of 164.43, Indivior Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indivior Pharmaceuticals's current Days Inventory of 350.17 is 113% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Indivior Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indivior Pharmaceuticals's current Days Inventory is 350.17, which is 42% above median its own 10-year median of 247.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indivior Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Indivior Pharmaceuticals (INDV) is currently considered Significantly Overvalued. The stock's GF Value™ is $22.98, compared to a current price of $41.82 — trading 82% above its estimated fair value. The current Days Inventory is 350.17, which is 42% above median its 10-year median of 247.16 and 113% above the Drug Manufacturers industry median of 164.43. Indivior Pharmaceuticals' overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Indivior Pharmaceuticals (INDV), the current Days Inventory is 350.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indivior Pharmaceuticals (INDV) Overvalued in 2026?
Based on GuruFocus' analysis, Indivior Pharmaceuticals stock appears to be overvalued.
The current stock price of $41.82 is trading 82% above its estimated GF Value™ of $22.98.
GuruFocus considers Indivior Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for INDV:
Days Inventory: 350.17 (42% above median its 10-year median of 247.16)
GF Value™: $22.98 vs. price of $41.82 (82% above fair value)
Industry Position: 113% above the Drug Manufacturers median (#662 of 916)
No single metric tells the full story. See the INDV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
69GF Score
Get the complete analysis for INDV
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INDV has been successfully added to your 
